MWM
HALO icon

MOKAN Wealth Management’s Halozyme HALO Stock Holding History

MOKAN Wealth Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,601
Closed -$491K – 109
2026
Q1 		$491K Buy
+7,601
New +$536K 0.22% 98

Other funds holding HALO

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

MOKAN Wealth Management's HALO Position: Q2 2026 in Review

MOKAN Wealth Management sold out of Halozyme (HALO) in Q2 2026, closing a stake of 7,601 shares — an estimated $491K sold.

MOKAN Wealth Management first reported a position in HALO in Q1 2026 and held it in 1 quarter. The position peaked at $491K in Q1 2026. 239 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • MOKAN Wealth Management reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • MOKAN Wealth Management sold 7,601 Halozyme shares in Q2 2026, an estimated $491K.
  • MOKAN Wealth Management first reported a position in Halozyme in Q1 2026 and held it in 1 quarter.
  • MOKAN Wealth Management's Halozyme position peaked at $491K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on MOKAN Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.